The Prophylactic Effect of Garlic Tablets to Prevent Nosocomial Infections in Intensive Care Unit Patients.
试验速览
- 阶段
- 3 期
- 状态
- Enrolling By Invitation
- 入组人数
- 62
- 试验地点
- 1
- 主要终点
- Occurrence of central line-associated bloodstream infections, catheter- associated urinary tract infections, surgical site infections and ventilator- associated pneumonia in the two groups (by cultures results).
研究概览
简要总结
The goal of this clinical trial is to learn if garlic tablets works to prevent nosocomial infections in hospitalized patients in ICU. The main questions it aims to answer are:
Does garlic tablets administration lower the occurence of nosocomial infections in hospitalized patients in ICU?
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Prevention
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 65 Years(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •All patients aged from 18 to 65 years old admitted to intensive care units without any type of infection.
排除标准
- •Patients with signs /symptoms of infection.
- •Patients with human immunodeficiency virus, malignancy and patients with a history of recent immunosuppressants or corticosteroids administration.
- •Patients with bleeding disorders or abnormal coagulation profile
- •Patients who will planned for surgery within 2 weeks.
研究组 & 干预措施
The intervention group
The patients in the intervention group which will receive garlic tablets (Tomex plus 300 mg) two tablets twice daily for 6 days just after ICU admission
干预措施: Garlic powder standardized to allicin (Drug)
结局指标
主要结局
Occurrence of central line-associated bloodstream infections, catheter- associated urinary tract infections, surgical site infections and ventilator- associated pneumonia in the two groups (by cultures results).
时间窗: one year
次要结局
- Values of Blood white cell count, body temperature and C-reactive protein of the patient in the two groups .(one year)
